MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4

Zhuoshi Li1,2, Shiqing Wang1,2, Tao Guo1,2

  • 1Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China.

Cell Death Discovery
|December 18, 2024
PubMed

Insights

Metastasis-associated in colon cancer-1 (MACC1) promotes lung cancer stem cell (CSC) development by stabilizing Krüppel-like factor 4 (KLF4) mRNA. This study reveals MACC1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer stem cells (CSCs) drive tumor growth and plasticity.
  • Non-CSCs can dedifferentiate into CSC-like cells.
  • The role of MACC1 in this transition is unclear.

Purpose of the Study:

  • Investigate MACC1's role in non-CSC to CSC transition in lung cancer.
  • Identify MACC1's molecular mechanisms regulating stemness.
  • Explore MACC1 as a therapeutic target for CSCs.

Main Methods:

  • Overexpression and knockdown studies of MACC1.
  • High-throughput sequencing.
  • Analysis of lung tumor specimens.
  • MicroRNA expression analysis.

Main Results:

  • MACC1 overexpression enhanced non-CSC to CSC transition.
  • MACC1 knockdown inhibited this transition.
  • MACC1 negatively correlated with KLF4 expression.
  • MACC1 repressed miR-25, stabilizing KLF4 mRNA.

Conclusions:

  • MACC1 promotes lung cancer stemness by post-transcriptionally regulating KLF4.
  • MACC1 is a potential therapeutic target for lung CSCs.
  • Understanding MACC1-KLF4 interaction is key for precision therapy.